Skip to main content

Animations

MJFF Publications

4031 - 4040 of 6256 Results
Title
Year
  • Year
  • 2020
  • 2018
  • 2021
  • 2020
  • 2021
  • 2022
  • 2015
  • 2025
  • 2018
  • 2022
  • Summary Details
    OPEN
    Title: The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2019103791
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/nan.12486
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2086
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51164
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3389/fneur.2021.656342
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03002-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13056
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.70078
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0245-9
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s Disease
    Journal Name: JACS Au
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacsau.2c00300
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.